Skip to content

MAC(TM) Two-Lumen Central Venous Access Set with Integral Hemostasis Valve for use with 7 - 7.5 Fr. Catheters

by Arrow International LLC (Subsidiary of Teleflex Incorporated)

Ref SI-11242

Active European Union. Also listed in GUDID (US).

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

1 ongoing

Recall on shared 510(k) K002507; other models may be affected

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, GUDID, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing GUDID Number10801902200010 UDI-DIDate28 Sep 2026ListedStatusListed GUDID: in commercial distribution
European UnionCE/MDR EUDAMED Number08019020000000000000103K3 Basic UDI-DIDate19 May 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Recalls

64 recalls · 1 ongoing · FDA

    • Ongoing Z-2385-2026 FDA Class I initiated 21 Apr 2026 on shared 510(k) K002507

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

  • 2 recalls, same reason

    • Terminated Z-0352-2023 FDA Class I initiated 27 Oct 2022
    • Terminated Z-0351-2023 FDA Class I initiated 27 Oct 2022

    There is the potential for inadequate connection between the top and bottom housings of the Micro Clave Clear Connectors included in the Arrow MAC Two-Lumen Central Venous Access Kit and the Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen CVC Kit.

    • Terminated Z-1323-2018 FDA Class II initiated 22 Dec 2017

    Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.

    • Terminated Z-2335-2017 FDA Class II initiated 9 May 2017

    Arrow International is recalling the affected product because the packaging may not be completely sealed, which may compromise sterility.

  • 53 recalls, same reason

    • Terminated Z-2288-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2287-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2298-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2304-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2290-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2292-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2269-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2262-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2302-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2293-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2301-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2281-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2256-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2272-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2268-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2275-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2265-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2277-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2289-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2274-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2282-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2276-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2300-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2299-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2284-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2258-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2283-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2296-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2291-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2270-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2259-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2254-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2286-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2257-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2273-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2278-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2295-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2260-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2279-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2297-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2266-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2255-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2285-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2264-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2267-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2263-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2305-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2303-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2261-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2280-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2253-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2271-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2294-2017 FDA Class II initiated 20 Mar 2017

    Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

  • 3 recalls, same reason

    • Terminated Z-2306-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2308-2017 FDA Class II initiated 20 Mar 2017
    • Terminated Z-2307-2017 FDA Class II initiated 20 Mar 2017

    The large-bore two-lumen catheter permits venous access to the central circulation for rapid fluid administration, temporary or acute hemodialysis, apheresis and hemofiltration. It may be inserted into the jugular, subclavian, or femoral veins. The ARROWg+ard Blue antimicrobial surface catheter helps provide protection against catheter-related infections resulting from microorganisms migrating the subcutaneous tract along the exterior surface of the catheter when used for infusion. Clinical data have not been collected that demonstrate the use of the ARROWg+ard Blue antimicrobial surface in decreasing catheterrelated infections in hemodialysis patients. The catheter is not intended to be used as a treatment for existing infections, nor is it indicated for long-term use.

    • Terminated Z-2825-2015 FDA Class II initiated 27 Aug 2015

    Manufacturer of 0.9% Sodium Chloride Flush Syringes recalled due to compromised sterility of the outer barrel, Arrow purchased recalled items that were packaged with certain products.

    • Terminated Z-2488-2010 FDA Unclassified (pre-2012) initiated 29 Jul 2010 on shared 510(k) K002507

    Incorrectly assembled 18 Ga x 2 1/2 Introducer Needle

    • Terminated Z-1496-2009 FDA Unclassified (pre-2012) initiated 11 Feb 2009 on shared 510(k) K002507

    Leakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade Name
MAC(TM) Two-Lumen Central Venous Access Set with Integral Hemostasis Valve for use with 7 - 7.5 Fr. Catheters EUDAMED
Arrow GUDID
Generic Name
Vascular catheter introduction set, nonimplantable
Device Name
Multi-Lumen Access Catheter (MAC) & Percutaneous Sheath Introducer (PSI) Product
Model / Ref / Catalog
SI-11242, IPNB00348
Primary DI / UDI-DI
10801902200010, 10801902226195
Basic UDI-DI
08019020000000000000103K3, 08019020000000000000121K5
510(k) Number
FDA Product Code
FOZ
EMDN Code
C0502 Cardiovascular introducer sheaths, valved
GMDN Term
Vascular catheter introduction set, nonimplantable
Device Class
Class IIb EUDAMED
Class II GUDID
Regulation Number
880.5200
Market of Registration
Ireland
Medical Purpose
The Arrow Multi-Lumen Central Venous Access Device permits venous access for procedures requiring large volume fluid infusion or catheter introduction to the central circulation
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / ReferenceEUDAMED
SI-11242
GUDID
IPNB00348
Device ClassEUDAMED
Class IIb
GUDID
Class II

Manufacturer details

EUDAMED SRN
US-MF-000024256
Authorised representative
Teleflex Medical IE-AR-000015869

Other devices from Arrow International LLC (Subsidiary of Teleflex Incorporated)

See all devices from Arrow International LLC (Subsidiary of Teleflex Incorporated) →

Properties

  • Sterile
  • Single Use
  • Reprocessed
  • CMR Substance
  • Animal Tissues
  • Convenience Kit
  • Lot / Batch Number
  • Expiration Date

Other properties (16)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No
  • Prescription Use: No
  • Over-the-Counter: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Serial Number: No
  • Manufacturing Date: No